Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7182 | 1319 | 36.9 | 51% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1482 | 7124 | OLFACTORY BULBECTOMY//CHRONIC MILD STRESS//LEARNED HELPLESSNESS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CENTPROPAZINE | Author keyword | 3 | 100% | 0% | 3 |
| 2 | ISOPRENALINE INDUCED DRINKING | Author keyword | 3 | 100% | 0% | 3 |
| 3 | BETA DOWN REGULATION | Author keyword | 3 | 60% | 0% | 3 |
| 4 | CLONIDINE INDUCED MYDRIASIS | Author keyword | 1 | 50% | 0% | 2 |
| 5 | CSIC CAJALASSOCIATE UNIT | Address | 1 | 50% | 0% | 2 |
| 6 | CSICASSOCIATE UNIT | Address | 1 | 50% | 0% | 2 |
| 7 | PLATELET ALPHA 2 ADRENOCEPTORS | Author keyword | 1 | 50% | 0% | 2 |
| 8 | POSTSYNAPTIC ALPHA 2 ADRENOCEPTORS | Author keyword | 1 | 100% | 0% | 2 |
| 9 | DOPA NORADRENALINE SYNTHESIS | Author keyword | 1 | 33% | 0% | 2 |
| 10 | ALPHA2A ADRENOCEPTORS | Author keyword | 1 | 18% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ADRENERGIC RECEPTOR SENSITIVITY | 15 | 88% | 1% | 7 |
| 2 | GROWTH HORMONE RESPONSE | 6 | 18% | 2% | 30 |
| 3 | H 3 YOHIMBINE BINDING | 6 | 100% | 0% | 4 |
| 4 | DEPRESSED MALE PATIENTS | 4 | 75% | 0% | 3 |
| 5 | PARA AMINOCLONIDINE BINDING | 3 | 35% | 1% | 8 |
| 6 | DEPRESSANT DRUG TREATMENT | 3 | 60% | 0% | 3 |
| 7 | H 3 CLONIDINE BINDING | 3 | 60% | 0% | 3 |
| 8 | CENTRAL ALPHA 2 ADRENOCEPTOR SENSITIVITY | 3 | 42% | 0% | 5 |
| 9 | CHRONIC DESIPRAMINE TREATMENT | 2 | 27% | 1% | 8 |
| 10 | ANTIDEPRESSANT DRUGS INCREASES | 2 | 30% | 0% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| TOWARD A DYSREGULATION HYPOTHESIS OF DEPRESSION - OVERVIEW | 1985 | 375 | 58 | 34% |
| alpha(2) adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapy | 2012 | 8 | 148 | 37% |
| ABNORMAL REGULATION OF NORADRENERGIC FUNCTION IN PANIC DISORDERS - EFFECTS OF CLONIDINE IN HEALTHY-SUBJECTS AND PATIENTS WITH AGORAPHOBIA AND PANIC DISORDER | 1986 | 250 | 57 | 25% |
| Platelet alpha(2A)-adrenoceptor function in major depression: G(i) coupling, effects of imipramine and relationship to treatment outcome | 1999 | 16 | 107 | 52% |
| The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies | 2011 | 21 | 116 | 18% |
| EFFECTS OF LONG-TERM ADMINISTRATION OF ANTIDEPRESSANTS AND NEUROLEPTICS ON RECEPTORS IN THE CENTRAL NERVOUS-SYSTEM | 1989 | 90 | 198 | 27% |
| EVALUATION OF STUDIES ON PLATELET ALPHA-2 ADRENOCEPTORS IN DEPRESSIVE-ILLNESS | 1986 | 53 | 80 | 71% |
| FLUOXETINE - A REVIEW OF RECEPTOR AND FUNCTIONAL-EFFECTS AND THEIR CLINICAL IMPLICATIONS | 1992 | 87 | 38 | 26% |
| Adrenergic receptor function in panic disorder - I. Platelet alpha(2) receptors: G(i) protein coupling, effects of imipramine, and relationship to treatment outcome | 1999 | 10 | 81 | 51% |
| PLATELET ALPHA-2-ADRENOCEPTORS IN DEPRESSION - A CRITICAL-EXAMINATION | 1993 | 17 | 88 | 44% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CSIC CAJALASSOCIATE UNIT | 1 | 50% | 0.2% | 2 |
| 2 | CSICASSOCIATE UNIT | 1 | 50% | 0.2% | 2 |
| 3 | CAIXA POSTAL 8091 | 1 | 50% | 0.1% | 1 |
| 4 | FELSENSTEIN MED GEHA PSYCHIAT HOSP | 1 | 50% | 0.1% | 1 |
| 5 | MED SCI PSYCHOPHARMACOL UNIT | 1 | 50% | 0.1% | 1 |
| 6 | NEUROBIOL RAMON CAJAL NEUROPHARMACOL | 1 | 50% | 0.1% | 1 |
| 7 | OBSTET GYNAECOL HORMONE | 1 | 50% | 0.1% | 1 |
| 8 | TRANSFUSIONSMED IMMUNOL | 1 | 50% | 0.1% | 1 |
| 9 | WALTER MACKENZIE PSYCHIAT | 1 | 50% | 0.1% | 1 |
| 10 | ASSOCIATE UNIT NEUROPHARMACOL | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000235787 | DRL BEHAVIOR//DRL 72 S SCHEDULE//BEHAVIORAL SCREEN |
| 2 | 0.0000182582 | MOUSE FORCED SWIMMING//FORCED SWIMMING TEST//TAIL SUSPENSION TEST |
| 3 | 0.0000124718 | ALPHA2 ADRENOCEPTOR SUBTYPES//ALPHA2 ADRENOCEPTOR SUBTYPE//ALPHA2C ADRENOCEPTOR |
| 4 | 0.0000122967 | H 3 IMIPRAMINE BINDING//IMIPRAMINE BINDING//H 3PAROXETINE BINDING |
| 5 | 0.0000091859 | POSTJUNCTIONAL ALPHA 2 ADRENOCEPTORS//UK14304//ALPHA 1 ADRENOCEPTORS |
| 6 | 0.0000090990 | INTACT CELL BINDING//DIABET METAB DIS PROGRAM//GENE REPRESSOR |
| 7 | 0.0000082505 | DSP 4//DSP 4 N 2 CHLOROETHYL N ETHYL 2 BROMOBENZYLAMINE//XYLAMINE |
| 8 | 0.0000081075 | INOSITOL MONOPHOSPHATASE//INOSITOL//INOSITOL DEPLETION |
| 9 | 0.0000070392 | PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT |
| 10 | 0.0000068375 | TRAZODONE//DESMETHYLMIANSERIN//ETOPERIDONE |